Concept:
Blinding (masking) in clinical trials is used to reduce bias by preventing participants and/or investigators from knowing which intervention is being administered.
- Single-blind: Only the participant is unaware.
- Double-blind: Both participant and investigator are unaware.
- Triple-blind: Participant, investigator, and data analyst are unaware.
- Open-label: No blinding.
Step 1: Understand purpose of blinding.
Blinding minimizes bias in outcome assessment, placebo effect, and treatment administration.
Step 2: Identify the most commonly used type.
Double-blind trials are most widely used because they effectively reduce both participant and observer bias.
Step 3: Compare with other types.
- Single-blind reduces only participant bias.
- Triple-blind is more rigorous but less commonly used.
- Open-label has no bias control.
Step 4: Conclude the answer.
Thus, the most commonly utilized blinding method in RCTs is double-blind.